Find Paid Clinical Trials in Kentucky

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Kentucky

Top of Directory » All Locations » United States » Kentucky




  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

    Condition:   Stage IV Melanoma
    Intervention:   Device: LC beads loaded with Doxorubicin
    Sponsors:   University of Louisville;   Thomas Jefferson University;   M.D. Anderson Cancer Center
    Recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment

    Conditions:   Traumatic Brain Injury;   Posttraumatic Stress Disorders;   Trauma;   Combat Disorders;   Pain
    Intervention:   Device: TMRDU
    Sponsors:   University of Illinois;   Department of Defense Telemedicine and Advanced Technology Research Center
    Not yet recruiting - verified November 2009

  • Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

    Conditions:   Bird Flu;   Influenza
    Interventions:   Other: Placebo;   Biological: Ad4-H5-Vtn
    Sponsor:   PaxVax, Inc.
    Recruiting - verified November 2009

  • RSP® Prospective Multi-Center Study

    Conditions:   Rotator Cuff Deficiency;   Shoulder Arthropathy;   Failed Shoulder Replacement
    Intervention:   Device: Encore Reverse Shoulder Prosthesis (RSP®)
    Sponsor:   Encore Medical, L.P.
    Not yet recruiting - verified October 2009

  • A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

    Conditions:   Excessive Daytime Sleepiness;   Narcolepsy
    Interventions:   Drug: Placebo;   Drug: PF-03654746
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Study of AHIST in Seasonal Allergic Rhinitis Patients

    Condition:   Rhinitis, Allergic, Seasonal
    Intervention:   Drug: AHIST NDC#58407-012-01
    Sponsor:   Magna Pharmaceuticals, Inc.
    Not yet recruiting - verified October 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • New Neural Drug Targets

    Condition:   Narcotic Abuse
    Interventions:   Drug: Aprepitant;   Drug: Placebo
    Sponsor:   University of Kentucky
    Not yet recruiting - verified October 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • TAXUS Libertē Post Approval Study

    Condition:   Coronary Artery Disease
    Interventions:   Device: TAXUS Liberté Paclitaxel-Eluting Coronary Stent;   Drug: prasugrel;   Drug: placebo;   Drug: aspirin
    Sponsors:   Boston Scientific Corporation;   Eli Lilly and Company;   Daiichi Sankyo Inc.
    Not yet recruiting - verified November 2009

  • SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

    Conditions:   Acute Lung Injury (ALI);   Acute Respiratory Distress Syndrome (ARDS)
    Interventions:   Drug: SB-681323 Intravenous 7.5mg;   Drug: SB-681323 Intravenous 3mg;   Drug: SB-681323 Intravenous 7.5 mg;   Drug: SB-681323 Intravenous 10mg;   Other: Placebo
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

    Condition:   Influenza
    Intervention:   Biological: Adjuvanted and un-adjuvanted influenza vaccines
    Sponsors:   Novartis;   Novartis Vaccines
    Recruiting - verified October 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

    Condition:   Psoriasis
    Interventions:   Drug: Methotrexate and Etanercept;   Drug: Etanercept ONLY
    Sponsors:   Amgen;   Immunex Corporation
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: tocilizumab;   Drug: placebo;   Drug: NSAIDs, corticosteroids, methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds

    Condition:   Human Papillomavirus Infection
    Interventions:   Biological: V503;   Biological: Comparator: Menactra™ (Concomitant);   Biological: Comparator: Adacel™ (concomitant);   Biological: Comparator: Menactra™ (Non-Concomitant);   Biological: Comparator: Adacel™ (Non-concomitant)
    Sponsor:   Merck
    Recruiting - verified November 2009

  • RELIEF: Healthcase Utilization and Outcomes of FinESS Treatment in the Office

    Condition:   Rhinosinusitis
    Intervention:   Device: FinESS Sinus Treatment
    Sponsor:   Entellus Medical, Inc.
    Recruiting - verified November 2009

  • Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

    Condition:   Gout
    Interventions:   Drug: placebo;   Drug: BCX4208
    Sponsor:   BioCryst Pharmaceuticals
    Recruiting - verified November 2009

  • Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL)

    Condition:   Typical Atrial Flutter
    Intervention:   Device: Therapy Cool Path Duo
    Sponsor:   St. Jude Medical
    Recruiting - verified November 2009

  • Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer

    Condition:   Liver Cancer
    Interventions:   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: liver transplantation;   Procedure: observation
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal

    Condition:   Substance Withdrawal Syndrome
    Interventions:   Drug: Tramadol;   Drug: Placebo
    Sponsor:   University of Kentucky
    Recruiting - verified November 2009

  • Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

    Condition:   Influenza Infection
    Interventions:   Biological: GSK2340273A;   Biological: GSK2340274A
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Study in Adolescents With Schizophrenia or Bipolar Disorder

    Conditions:   Bipolar I Disorder;   Schizophrenia
    Interventions:   Drug: Olanzapine;   Behavioral: Standard behavioral weight intervention;   Behavioral: Intense behavioral weight intervention
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • The Dual Antiplatelet Therapy Study (DAPT Study)

    Condition:   Coronary Artery Disease
    Interventions:   Drug: Placebo & Aspirin;   Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin
    Sponsors:   Harvard Clinical Research Institute;   Abbott;   Boston Scientific Corporation;   Bristol-Myers Squibb;   Sanofi-Synthelabo;   Cordis Corporation;   Eli Lilly and Company;   Daiichi Sankyo Inc.;   Medtronic
    Recruiting - verified November 2009

  • A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: insulin glargine + preprandial lispro insulin;   Biological: albiglutide + insulin glargine
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

    Condition:   Influenza Infection
    Interventions:   Biological: GSK2340273A;   Biological: GSK2340274A
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

    Condition:   Severe Nodular Acne
    Intervention:   Drug: CIP-Isotretinoin and Isotretinoin
    Sponsor:   Cipher Pharmaceuticals Inc.
    Recruiting - verified November 2009

  • Efficacy and Safety Study of NBI-56418 Na in Subjects With Endometriosis

    Conditions:   Endometriosis;   Pain
    Interventions:   Drug: NBI-56418;   Drug: Placebo
    Sponsor:   Neurocrine Biosciences
    Recruiting - verified November 2009

  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

    Conditions:   Osteoarthritis;   Osteoarthritis, Hip;   Osteoarthritis, Knee;   Pain;   Arthralgia;   Joint Pain
    Interventions:   Drug: JNJ-42160443;   Drug: Placebo;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Placebo;   Drug: Dutogliptin
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified November 2009

  • Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate

    Conditions:   Chronic Kidney Disease;   Chronic Renal Disease
    Intervention:   Other: Dialysis Flow Rate
    Sponsors:   Gambro Renal Products, Inc.;   University of Louisville;   Vanderbilt University;   University of California, Davis
    Recruiting - verified November 2009

  • Study of Blood Samples From Newborns With Down Syndrome

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult and Adolescent Hospitalized Subjects With Confirmed or Suspected Influenza Infection

    Conditions:   Seasonal Influenza;   Cough;   Sore Throat;   Nasal Congestion;   Myalgia;   Headache;   Feverishness;   Fatigue
    Interventions:   Drug: Peramivir;   Drug: Peramivir
    Sponsors:   BioCryst Pharmaceuticals;   Department of Health and Human Services
    Recruiting - verified November 2009

  • A Study in Relapse Prevention of Treatment-resistant Depression

    Condition:   Treatment Resistant Depression
    Interventions:   Drug: Olanzapine and Fluoxetine combination;   Drug: Fluoxetine
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

    Condition:   Subjective Tinnitus
    Interventions:   Drug: Neramexane mesylate;   Drug: Placebo
    Sponsor:   Merz Pharmaceuticals GmbH
    Recruiting - verified November 2009

  • COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

    Condition:   Myelofibrosis
    Interventions:   Drug: INCB018424;   Drug: Placebo
    Sponsor:   Incyte Corporation
    Recruiting - verified November 2009

  • Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II or Stage III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

    Conditions:   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
    Interventions:   Biological: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • AMG 827 in Rheumatoid Arthritis Subjects With Inadequate Response to Methotrexate

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: AMG 827 140 mg;   Drug: AMG 827 210 mg;   Drug: Placebo;   Drug: AMG 827 70 mg
    Sponsor:   Amgen
    Not yet recruiting - verified November 2009

  • Study of Patients With Advanced Non-Small Cell Lung Cancer

    Condition:   Advanced Non-Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Paclitaxel;   Biological: Bevacizumab
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

    Condition:   Lung Cancer
    Interventions:   Biological: bevacizumab;   Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Dutogliptin;   Drug: Placebo
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified October 2009

  • Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

    Conditions:   Kidney Cancer;   Precancerous/Nonmalignant Condition
    Interventions:   Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of V503 in Preadolescents and Adolescents

    Conditions:   Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Lesions;   PAP Test Abnormalities;   HPV Infections
    Intervention:   Biological: V503
    Sponsor:   Merck
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials